The Court of Milan declared the Bankruptcy of Marvecspharma Service srl with sentence N 09/2011 issued on 13 January and filed on 14 January.
One of the worst stories (and there are many!) involving the pharmaceutical industry in general and the world of scientific information in particular has come to an end.
Our full and complete solidarity reaches out to the Marvecs colleagues [Editor's note].
Now everything passes into the hands of the Bankruptcy Trustee, who will have to draw up a passive state (ie the list of all debts) and an active balance sheet (ie receivables to be collected, value of molecules to be sold, drugs in stock, cash). On the basis of the assets realized, the creditors on the basis of the legal privileges must be satisfied, first, and then the unsecured ones (ie those without privileges).
Employment relationships are understood to be terminated and all creditors must submit an insinuation to the state of liabilities 30 days before the verification hearing.
The Curator can also exercise actions for the recovery of the damaged assets and prosecute those responsible for the damage.
